Index of reports
> Cases with Foetal Exposure During Pregnancy (14)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Progesterone where reactions include foetal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Progesterone side effects in male
Reported by a physician from Greece on 2012-05-09
Patient: male
Reactions: Caesarean Section, Maternal Drugs Affecting Foetus, Apgar Score LOW, Premature Baby, Foetal Exposure During Pregnancy, Gastroenteritis
Drug(s) suspected as cause:
Folic Acid
Indication: Maternal Exposure Timing Unspecified
Paricalcitol
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Vitamin B Complex CAP
Indication: Maternal Exposure Timing Unspecified
Other drugs received by patient: Levocarnitine; Darbepoetin Alfa; Sevelamer Hydrochloride
Possible Progesterone side effects in male
Reported by a physician from United States on 2012-02-28
Patient: male, weighing 3.3 kg (7.3 pounds)
Reactions: Foetal Exposure During Pregnancy, Drug Withdrawal Syndrome Neonatal
Drug(s) suspected as cause:
Neurontin
Dosage: (600 mg bid transplacental)
Indication: Neuropathy Peripheral
End date: 2011-09-27
Progesterone
Dosage: (dosing details unknown transplacental)
Indication: Shortened Cervix
End date: 2011-09-27
Suboxone
Dosage: (dosing information unknown transplacental)
Indication: Product Used FOR Unknown Indication
End date: 2011-09-27
Xanax
Dosage: (2 mg tid transplacental)
Indication: Anxiety
End date: 2011-09-27
Other drugs received by patient: Multi-Vitamins
Possible Progesterone side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-13
Patient:
Reactions: Digeorge's Syndrome, Foetal Exposure During Pregnancy, Foetal Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Aspirin
Indication: Foetal Exposure Timing Unspecified
Dexamethasone
Indication: Foetal Exposure Timing Unspecified
Enoxaparin Sodium
Indication: Foetal Exposure Timing Unspecified
Humira
Indication: Foetal Exposure Timing Unspecified
Immune Globulin Intravenous (Human)
Indication: Foetal Exposure Timing Unspecified
Immune Globulin Intravenous (Human)
Progesterone
Indication: Foetal Exposure Timing Unspecified
Possible Progesterone side effects in female
Reported by a health professional (non-physician/pharmacist) from Belgium on 2011-11-28
Patient: female
Reactions: Premature Baby, Foetal Exposure During Pregnancy, Hyperglycaemia, Jaundice Neonatal, Pulmonary Haemorrhage, Bradycardia, Cardiac Arrest, Apnoea
Adverse event resulted in: death
Drug(s) suspected as cause:
Progesterone
Possible Progesterone side effects in female
Reported by a health professional (non-physician/pharmacist) from Belgium on 2011-11-18
Patient: female
Reactions: Premature Baby, Foetal Exposure During Pregnancy, Hyperglycaemia, Jaundice Neonatal, Pulmonary Haemorrhage, Bradycardia, Apnoea, Cardiac Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Progesterone
Possible Progesterone side effects in female
Reported by a consumer/non-health professional from Brazil on 2011-11-02
Patient: female
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Nuvaring
Dosage: unk;trpl
Indication: Pregnancy
Start date: 2010-10-17
End date: 2010-11-19
Progesterone
Dosage: unk;trma
Indication: Menometrorrhagia
Start date: 2011-01-01
End date: 2011-06-01
Progesterone
Dosage: unk;trma
Indication: Placental Disorder
Start date: 2011-01-01
End date: 2011-06-01
|